Document ID: chunk:federal_register_of_legislation:F2025C00217:schedule:2:p1
Version: federal_register_of_legislation:F2025C00217
Segment Type: schedule
Provision Reference: sch 2 (pt 1/4)
Character Range: 145597–151031

Schedule 2—Pharmaceutical benefits for which the Commonwealth will pay the special patient contribution

Note: See section 8.

Listed Drug   Form                                                                    Manner of Administration  Brand     Circumstances
 Amoxicillin   Powder for paediatric oral drops 100 mg (as trihydrate) per mL, 20 mL   Oral                      Amoxil   Infection suspected or proven to be due to a susceptible organism
                                                                                                                          The treatment must be for patients who require a liquid formulation and in whom the syrup formulations are unsuitable
Eprosartan    Tablet 600 mg (as mesilate)                                             Oral                      Teveten   Adverse effects occurring with all of the base‑priced drugs.
                                                                                                                          Drug interactions occurring with all of the base‑priced drugs.
                                                                                                                          Drug interactions expected to occur with all of the base‑priced drugs.
                                                                                                                          Transfer to a base‑priced drug would cause patient confusion resulting in problems with compliance
 Naratriptan   Tablet 2.5 mg (as hydrochloride)                                        Oral                      Naramig  Migraine attack
                                                                                                                          The condition must have usually failed to respond to analgesics in the past; AND
                                                                                                                          Patient must be one in whom transfer to another suitable PBS‑listed drug would cause patient confusion resulting in problems with compliance.
                                                                                                                          Migraine attack
                                                                                                                          The condition must have usually failed to respond to analgesics in the past; AND
                                                                                                                          Patient must be one in whom transfer to another suitable PBS‑listed drug is likely to result in adverse clinical consequences.
                                                                                                                          Migraine attack
                                                                                                                          The condition must have usually failed to respond to analgesics in the past; AND
                                                                                                                          Patient must be one in whom adverse events have occurred with other suitable PBS‑listed drugs.
                                                                                                                          Migraine attack
                                                                                                                          The condition must have usually failed to respond to analgesics in the past; AND
                                                                                                                          Patient must be one in whom drug interactions are expected to occur with other suitable PBS‑listed drugs.
                                                                                                                          Migraine attack
                                                                                                                          The condition must have usually failed to respond to analgesics in the past; AND
                                                                                                                          Patient must be one in whom drug interactions have occurred with other suitable PBS‑listed drugs.

Endnotes

Endnote 1—About the endnotes
The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4
Amending laws are annotated in the legislation history and amendment history.

The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.

The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with